CFDE Data Portal | Search CALCB

	Label	Description
	CALCB Gene (Entity type)	ENSG00000175868 - calcitonin related polypeptide beta
	CALCB associations Collection (Entity type)	Associations for CALCB_associations
	CALCB associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CALCB HUMAN Protein (Entity type)	Calcitonin gene-related peptide 2 (precursor)
	CALCB RAT Protein (Entity type)	Calcitonin gene-related peptide 2 (precursor)
	CALCB MOUSE Protein (Entity type)	Calcitonin gene-related peptide 2 (precursor)
	GSE158834 ADIPOR2 knockout HEK293 1 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 1 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE187006 3 V 2 VALPROIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE169356 ivermectin prostate gland 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

CALCB

ENSG00000175868 - calcitonin related polypeptide beta

CALCB associations

Associations for CALCB_associations

CALCB associations.tsv

A file from IDG as part of the Harmonizome project

CALCB HUMAN

Calcitonin gene-related peptide 2 (precursor)

CALCB RAT

Calcitonin gene-related peptide 2 (precursor)

CALCB MOUSE

Calcitonin gene-related peptide 2 (precursor)

GSE158834 ADIPOR2 knockout HEK293 1 v 6 human dn

A Gene Set from LINCS

GSE239844 crizotinib 1 v 10 human dn

A Gene Set from LINCS

GSE187006 3 V 2 VALPROIC ACID HUMAN UP

A Gene Set from LINCS

GSE169356 ivermectin prostate gland 0 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.